日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of immune checkpoint inhibitors in patients with high microsatellite instability/mismatch repair-deficient advanced cholangiocarcinoma: A propensity score-matched study

免疫检查点抑制剂治疗高微卫星不稳定性/错配修复缺陷型晚期胆管癌患者的疗效和安全性：一项倾向评分匹配研究

期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2026.101816
Piao, Mingjian; Yang, Xu; Li, Chengjie; Zhao, Jiayi; Zhang, Nan; Li, Jiongyuan; Huang, Ziyue; Li, Shuofeng; Sun, Boyu; Yang, Xiaobo; Zhao, Haitao
肿瘤
胆管癌
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Local-regional therapy plus ICIs, chemotherapy, and lenvatinib versus ICIs plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter study

局部区域治疗联合免疫检查点抑制剂、化疗和乐伐替尼与免疫检查点抑制剂联合化疗治疗晚期肝内胆管癌的疗效比较：一项多中心研究

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04259-x
Wang, Mingming; Li, Shuofeng; Yu, Guanhua; Zhang, An; Ding, Shikang; Zhang, Yihong; Feng, Shi; Zhou, Zixiang; Piao, Mingjian; Pan, Weixuan; Li, Chengjie; Sun, Boyu; Li, Jiongyuan; Zhang, Nan; Chen, Xinyuan; Sun, Yongliang; Zhang, Wen; Zhu, Zhenyu; Zhao, Haitao
肿瘤
胆管癌
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Conversion Surgery after Immune Checkpoint Inhibitor-Based Combination Therapy for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study

免疫检查点抑制剂联合治疗后行转化手术治疗初始不可切除的肝细胞癌：一项回顾性队列研究

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000543994
Piao, Mingjian; Li, Chengjie; Huang, Ziyue; Zhang, Nan; Li, Jiongyuan; Yang, Xu; Li, Shuofeng; Wang, Shanshan; Xun, Ziyu; Zhang, Longhao; Sun, Boyu; Zhang, Ting; Yang, Xiaobo; Zhao, Haitao
Checkpoint
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Single-cell transcriptomic analysis deciphers the inflammatory microenvironment characterized by CXCL9+ fibroblasts and ACKR1+ endothelial cells in immune-related myocarditis

单细胞转录组分析揭示了免疫相关性心肌炎中以CXCL9+成纤维细胞和ACKR1+内皮细胞为特征的炎症微环境

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06551-x
Sun, Boyu; Xun, Ziyu; Zhou, Zixiang; Zhang, Nan; Piao, Mingjian; Li, Chengjie; Li, Jiongyuan; Li, Shuofeng; Zhang, Longhao; Chen, Xiangqi; Wang, Hanping; Zhao, Haitao
CXCL9
成纤维细胞
炎症
单细胞
心肌炎
炎症/感染
心血管
内皮细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Efficacy and safety of local-regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study

局部区域治疗联合化疗、免疫检查点抑制剂和乐伐替尼一线治疗晚期肝内胆管癌的疗效和安全性：一项多中心回顾性队列研究

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04085-1
Li, Shuofeng; Yu, Guanhua; Wang, Mingming; Feng, Shi; Wang, Shanshan; Piao, Mingjian; Li, Chengjie; Zhou, Zixiang; Xun, Ziyu; Sun, Boyu; Li, Jiongyuan; Zhang, Nan; Li, Hu; Yang, Xiaobo; Zhu, Zhenyu; Zhao, Haitao
免疫/内分泌
胆管癌
肿瘤免疫
肿瘤
发表日期：2025
文献求助 收藏

Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma

局部治疗克服了不可切除肝细胞癌对靶向免疫疗法联合治疗的原发性耐药性

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04184-z
Chen, Xiangqi; Piao, Mingjian; Zhou, Zixiang; Wang, Shanshan; Li, Shuofeng; Zhang, Nan; Sun, Boyu; Liu, Kai; Yang, Xu; Yang, Xiaobo; Shi, Xiaohua; Zhu, Chengpei; Zhao, Haitao
免疫/内分泌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Local-regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort study

局部区域治疗联合免疫检查点抑制剂和乐伐替尼与免疫检查点抑制剂联合化疗治疗晚期肝内胆管癌的疗效比较：一项多中心队列研究

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04129-6
Li, Shuofeng; Yu, Guanhua; Wang, Mingming; Feng, Shi; Zhang, An; Wu, Yu; Zhou, Zixiang; Wang, Shanshan; Zhang, Yihong; Piao, Mingjian; Li, Chengjie; Xun, Ziyu; Sun, Boyu; Li, Jiongyuan; Zhang, Nan; Li, Hu; Sun, Yongliang; Zhang, Wen; Zhu, Zhenyu; Zhao, Haitao
免疫/内分泌
胆管癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer

免疫疗法的改变克服了不可切除胆道癌化疗-免疫疗法后产生的耐药性

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04181-2
Chen, Xiangqi; Zhou, Zixiang; Li, Shuofeng; Yu, Guanhua; Feng, Shi; Zhou, Ze; Sun, Boyu; Wang, Shanshan; Liu, Kai; Li, Chengjie; Piao, Mingjian; Wang, Mingming; Zhang, Yihong; Li, Hu; Zhu, Chengpei; Zhu, Zhenyu; Zhao, Haitao
肿瘤
胆管癌
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Sphingosine kinase 1 promotes M2 macrophage infiltration and enhances glioma cell migration via the JAK2/STAT3 pathway

鞘氨醇激酶1通过JAK2/STAT3通路促进M2巨噬细胞浸润并增强胶质瘤细胞迁移。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-88328-2
Song, Zihan; Zhao, Zijun; Liu, Xuehua; Song, Yiran; Zhu, Siyu; Jia, Ziyang; Li, Yijie; Wang, Zairan; Sun, Boyu; Jin, Qianxu; Zhang, Shiyang; Zhao, Zongmao; Liu, Liqiang
巨噬细胞
细胞生物学
JAK/STAT
信号转导
巨噬细胞
JAK2
STAT3
胶质瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Real-world outcomes of first-line immunotherapy and subsequent systemic therapies in pleural mesothelioma: a multicenter study in China

中国一项多中心研究：一线免疫疗法及后续全身疗法治疗胸膜间皮瘤的真实世界疗效

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-1-1347
Tian, Binhe; Sun, Boyu; Zhou, Zixiang; Kuang, Shuman; Li, Jiongyuan; Pan, Weixuan; Zhu, Zhe; Si, Xiaoyan; Zhang, Li; Liu, Jun; Shi, Juhong; Wu, Fang; Zhao, Haitao; Wang, Hanping
免疫/内分泌
发表日期：2025
文献求助 收藏